The high-growth industry certainly offers terrific prospects that would be envied by many tech stocks. However, a big hurdle for some investors is investing in “sin stocks,” or what could be perceived as unethical industries and businesses.
There’s a massive Canadian marijuana news story that we’ve been following for over a year here at Money Morning. The news could lead to the Canadian cannabis industry growing by 400% in just four years, and you can profit by getting in right now…
Despite strong opposition from former White House Press Secretary Sean Spicer and Attorney General Jeff Sessions, and the overall limitations imposed by federal illegality in the U.S., 2017 is shaping up to be a great year for the North American cannabis industry.
Legal pot sales rose a stunning 34% in 2016 to $6.7 billion across North America, according to Arcview Market Research. But with growth this rapid, there’s bound to be more than a few marijuana stock investments that will be left behind.
Marijuana stock investors are going to have to keep their eyes on the following two critical data points for each and every marijuana stock they’re considering buying, or that they already own.
There are three different general types of marijuana stocks on the market. Some are marijuana growers. Others provide supplies to marijuana growers. Then there’s the third type: the biotechs. Zynerba Pharmaceuticals belongs to the last kind of marijuana stock.
Only 51 authorized licenses have been given to suppliers of medical marijuana in Canada. Canopy Growth Corporation holds four of them.
Since Justin Trudeau’s election, the Canadian cannabis space has seen significant growth both in public and private sectors. The industry is gearing up for its entry into the legal recreational cannabis market set to open up by July 1, 2018.
Here’s why Scotts Miracle-Gro Company, GW Pharmaceuticals, and Canopy Growth Corporation are three stocks to buy if you’ve never bought a cannabis stock.
Warren Buffett is well known as the most successful investor of all time. Buffett spent his formative years under the tutelage of Benjamin Graham, who is known today as the “father of value investing.” Let’s see whether or not Aphria Inc. can pass Buffett’s mentor’s criteriea test.
Mexican medical marijuana businesses and their investors will have a long time to wait before seeing profits from the newly legalized industry.
On July 1, 2017, Nevada will legalize the use and sale of recreational marijuana, which could be a catalyst for long-term gains for three cannabis stocks.
The industry and the Canopy Growth Corp. were going to be the next big thing for investors, but things have cooled down gradually over the past few months.
It is apparent that Aphria Inc. will be one of the major winners among marijuana companies. The timing of when to buy shares might be a bit tougher, though.
The questions surrounding marijuana legalization have pushed many to wonder about the possibility of a marijuana stock bubble. And for good reason.
Countries around the globe are embracing legal medicinal or recreational cannabis, and the industry is reacting accordingly.
Today we’re going to share seven essential tips that will help you save both time and money and invest in cannabis stocks as profitably as possible.
With multiple companies showing returns of more than 100%, you have what has turned into one of the more attractive sectors for investors in 2017. But is this the right move? Are marijuana stocks worth it? Most importantly, is now the time to invest in marijuana stocks?
You definitely don’t want to bet the family farm on such a speculative investment like Aurora Cannabis Inc., but there’s a substantial amount of upside if you don’t mind the large amount of risk.
On April 20, 2017, Cowen and Company, a leading Wall Street investment bank, issued a report that shows the accelerated adoption of cannabis pressuring alcohol volumes, with beer most at risk.
These 3 marijuana stocks make for some of the best investments in the cannabis industry for risk-averse investors.
Medical marijuana remains the safest investment route — if you’re forced to choose one — so here’s a brief rundown of the cannabinoid-based drugs working their way through clinical and preclinical trials.
Although marijuana stocks have skyrocketed in the last couple of years, many investors have been understandably leery of jumping on board. Check out why investors might like these three stocks that don’t fit the mold of most marijuana stocks.
This past week brought a first for the investment world — a medical marijuana electronic-traded fund (ETF) made its debut.
There are very few industries generating as much buzz as the medical and recreational marijuana markets are these days. With legislation across the world generally trending toward the legalization—or at least decriminalization of the drug—growth potential is strong, with investors seeking out “the best marijuana stocks to buy 2017.”
Many companies are set to prosper under this new segment of the economy, and licensed producer of marijuana, Aphria Inc, is set flourish under such conditions.
While the potential market is huge, there’s just one problem. All of Canada’s marijuana stocks are so expensive that no valuation-based investor will touch them. Fortunately, there are ways investors can have their cake and eat it too. All you need to do is identify industries that will get a nice bump from legal pot.
Aphria Inc. is the newest weed company to graduate to the TSX. The stock has been faring better than its peers, Canopy Growth Corp. and Aurora Cannabis Inc. over the past few months.
Beyond the legal issues, the problem for investors is that the industry is filled with small publicly traded companies that are risky bets at best, and outright fraudulent at worst.
Legal marijuana flat-Earthers, like U.S. Attorney General Jeff Sessions, have tried many methods to discredit breakthroughs in medical cannabis, but these efforts at discrediting cannabis stop at the U.S. border.
Marijuana has quickly become the next “can’t miss” investing idea for investors across North America. Despite this huge potential market, people are reluctant to put any of their cash into this market
There are a number of big institutions, including mutual funds, pension funds, and investment banks, that use the TSX Composite and its sub-indices as performance benchmarks for their portfolios. The addition of Canopy to the index will introduce some new dimensions to the index’s performance.
The cannabis industry’s excitement is building as the California takes steps towards establishing its legal recreational market. This week Los Angeles voters approved Measure M to create regulations for adult-use marijuana, thus setting up the city to steal the title of marijuana capital from Denver.
An industry previously only regulated by law enforcement leaves tremendous uncertainty for those looking to get into the industry from an investment perspective. Organizations like MJIC are stepping up to provide regulatory support and protection for marijuana operators.
While it is still difficult to invest directly in legal pot through public equities, venture capital firms and private equity funds have raised hundreds of millions of investment dollars.
Proceed with caution, said a number of speakers taking part in the California Cannabis Business Expo, which runs through Wednesday at the San Diego Sheraton Hotel and Marina.
Advocates, investors and entrepreneurs believe that the profile of marijuana users will change now that cannabis is legal. They all have one thing in common — wanting to make money from the new cannabis consumer.
Investors in cannabis companies had an eventful 2016 with the approval of recreational marijuana usage in the states of California, Massachusetts, Maine, and Nevada providing a boost to all sorts of marijuana stocks. Of particular note, shares of Corbus Pharmaceuticals (NASDAQ: CRBP) posted a whopping 600% gain in 2016 following positive phase 2 data.
Canopy Growth’s recently acquired Mettrum Ltd. stated that it wrote off $800,000 of costs owing to a series of recalls over the use of a banned pesticides. The staff at Mettrum feared detection from authorities, so they hid the pesticides in the office’s ceiling tiles.
Over the next five years, the U.S. marijuana market could be worth tens of billions of dollars, and according to GreenWave Advisors, LLC, these five states could move the needle most for marijuana companies. Learn just how big the marijuana market may be in California, Washington, Pennsylvania, Colorado, and Michigan in 2021.
The cannabis industry is expected to reach $50 billion in size by 2026, according to Cowen & Co., making it one of the fastest growing industries in the world. Investors have taken a growing interest in the industry as legalization has spread across North America. Here are three subsets of the cannabis industry that investors may want to consider for the best risk-adjusted returns.
Investors are incredibly excited about Canopy Growth Corporation. But we’re now looking at a situation where the stock has increased quite aggressively thanks mostly to the belief that the future is bright. And there are still many investors sitting on the sidelines wondering if they should consider this company.
On the face of it, 2017 may be the year to jump into the marijuana market to get a piece of what looks to be promising growth over the next few years.
Chris Blake, Senior Portfolio Manager, TD Wealth, explains what investors need to know before buying marijuana stocks.
Florida is undeniably behind the curve when it comes to passing pro-pot legislation, but the Sunshine State did make up some ground in November, when voters legalized medical marijuana in the state. How big could the medical marijuana market be in Florida for marijuana stocks?
Forward-thinking investors are already plotting seven-figure weed windfalls with the top pot stocks from every ecosystem. You see, there’s more to the marijuana industry than just selling cannabis. There are a lot of ways to profit from legal recreational and medical marijuana sales.
Investing in cannabis stocks is being called the “gold rush” of the 21st century. That’s because legal marijuana sales in North America climbed to $6.7 billion in 2016.
Sales in the legal marijuana industry are skyrocketing, which is why Money Morning created a list of the top marijuana stocks to watch in 2017. But because marijuana is still illegal under federal law, and many of the marijuana stocks on the market are so volatile, this isn’t a list of recommendations. Rather, it’s a list of marijuana stocks they are watching closely in 2017.
Most myths have at least a little bit of truth interspersed with a lot that is false. That’s the case with these three myths about marijuana stocks that some might mistakenly believe.
If you’re considering investing in marijuana stocks in the new year, here are five numbers you should know before taking the plunge.